Avadel Pharmaceuticals (AVDL) Shares Outstanding (Weighted Average): 2009-2022
Historic Shares Outstanding (Weighted Average) for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Sep 2022 value amounting to $59.8 million.
- Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) rose 2.04% to $59.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $59.8 million, marking a year-over-year increase of 2.04%. This contributed to the annual value of $58.6 million for FY2021, which is 0.60% up from last year.
- As of Q3 2022, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $59.8 million, which was up 1.28% from $59.0 million recorded in Q2 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) peaked at $59.8 million during Q3 2022, and registered a low of $36.7 million during Q2 2018.
- Over the past 3 years, Avadel Pharmaceuticals' median Shares Outstanding (Weighted Average) value was $58.5 million (recorded in 2021), while the average stood at $57.6 million.
- As far as peak fluctuations go, Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) dropped by 11.19% in 2018, and later skyrocketed by 55.61% in 2020.
- Quarterly analysis of 5 years shows Avadel Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $37.0 million in 2018, then climbed by 1.18% to $37.5 million in 2019, then skyrocketed by 55.60% to $58.3 million in 2020, then increased by 0.60% to $58.6 million in 2021, then rose by 2.04% to $59.8 million in 2022.
- Its last three reported values are $59.8 million in Q3 2022, $59.0 million for Q2 2022, and $59.0 million during Q1 2022.